Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Most Americans concerned about rising drugs costs amid COVID-19, Gallup says

By Sean Whooley | June 22, 2020

coronavirus COVID-19

[Photo by Fusion Medical Animation on Unsplash]

A new study by West Health and Gallup revealed that Americans are concerned with potential negative developments resulting from the COVID-19 pandemic.

Nearly 90% of the 1,016 U.S. adults surveyed between May 11, 2020, and May 22, 2020, said they are “very” (55%) or “somewhat” (33%) concerned that the pharmaceutical industry will leverage the ongoing pandemic to raise drug prices. According to a news release, Democrats (66%) were more likely to say they are concerned than independents (52%) and Republicans (49%).

Other concerns raised include, to a lesser extent, rising health insurance premiums and the general cost of care, with 79% of those surveyed saying they are very or somewhat concerned about their premiums. Additionally, 84% said they are very or somewhat concerned about the cost of care generally rising and 41% are very concerned about each.

Nearly half (48%) of women polled were very concerned about the general cost of care rising, while 33% of men were in the same bracket. Additionally, 50% of non-whites are very concerned, compared to 36% of whites. About 88% of those polled support direct negotiations by the federal government with a drug manufacturer on the price of treatment for the disease itself.

Gallup and West Health concluded that, with 14% of Americans refusing to seek treatment for COVID-19 symptoms because of the cost of care, leaders may consider policy decisions designed to curtail the possibilities of raised costs, easing the fears of the public.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Biogen logo
Biogen is scaling back space outside Boston
Fresenius Kabi
Fresenius Kabi plans to add 2D barcodes to its pharmaceutical portfolio
Dollars for drugs
Democrats’ drug pricing plan attracts pushback from Republicans
GBT/Pfizer
Pfizer to scoop up Global Blood Therapeutics for $5.4 billion 

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards